1. Home
  2. SBFM vs OCTO Comparison

SBFM vs OCTO Comparison

Compare SBFM & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • OCTO
  • Stock Information
  • Founded
  • SBFM 2006
  • OCTO 1966
  • Country
  • SBFM United States
  • OCTO United States
  • Employees
  • SBFM N/A
  • OCTO N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • OCTO
  • Sector
  • SBFM Health Care
  • OCTO
  • Exchange
  • SBFM Nasdaq
  • OCTO Nasdaq
  • Market Cap
  • SBFM 3.7M
  • OCTO 3.4M
  • IPO Year
  • SBFM N/A
  • OCTO N/A
  • Fundamental
  • Price
  • SBFM $3.00
  • OCTO $2.48
  • Analyst Decision
  • SBFM
  • OCTO
  • Analyst Count
  • SBFM 0
  • OCTO 0
  • Target Price
  • SBFM N/A
  • OCTO N/A
  • AVG Volume (30 Days)
  • SBFM 153.8K
  • OCTO 5.5M
  • Earning Date
  • SBFM 11-11-2024
  • OCTO 11-12-2024
  • Dividend Yield
  • SBFM N/A
  • OCTO N/A
  • EPS Growth
  • SBFM N/A
  • OCTO N/A
  • EPS
  • SBFM N/A
  • OCTO N/A
  • Revenue
  • SBFM $30,481,982.00
  • OCTO $55,497,449.00
  • Revenue This Year
  • SBFM $86.70
  • OCTO N/A
  • Revenue Next Year
  • SBFM $126.76
  • OCTO N/A
  • P/E Ratio
  • SBFM N/A
  • OCTO N/A
  • Revenue Growth
  • SBFM 109.82
  • OCTO N/A
  • 52 Week Low
  • SBFM $2.42
  • OCTO $1.26
  • 52 Week High
  • SBFM $660.00
  • OCTO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 46.45
  • OCTO 56.51
  • Support Level
  • SBFM $2.85
  • OCTO $1.78
  • Resistance Level
  • SBFM $3.05
  • OCTO $2.51
  • Average True Range (ATR)
  • SBFM 0.15
  • OCTO 0.21
  • MACD
  • SBFM 0.02
  • OCTO -0.01
  • Stochastic Oscillator
  • SBFM 43.59
  • OCTO 79.55

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.

Share on Social Networks: